Stomach cancer

• Health & Medicine

Scientists develop a breath test that could detect stomach cancers

A new type of breath test that detects nanoparticles could help diagnose stomach cancers, according to a study published in the British Journal of Cancer. A new type of breath test that detects nanoparticles could help diagnose stomach cancers, according to a study published in the British Journal of Cancer.

6 March 2013

• Health & Medicine

Docetaxel significantly increases survival for incurable gastric cancers

Survival for advanced stomach and oesophagael cancer patients increases by 40 per cent when treated with the chemotherapy drug, Docetaxel – providing evidence to prescribe it as a second-line treatment, according to the results of a Cancer Research UK trial presented at the American Society of Clinical Oncology (ASCO) Gastrointestinal cancers symposium today. Survival for advanced stomach and oesophagael cancer patients increases by 40 per cent when treated with the chemotherapy drug, Docetaxel – providing evidence to prescribe it as a second-line treatment, according to the results of a Cancer Research UK trial presented at the American Society of Clinical Oncology (ASCO) Gastrointestinal cancers symposium today.

23 January 2013

Trial launch of urgently-needed combination treatment for oesophago-gastric cancer

Cancer Research UK’s Drug Development Office (DDO), in collaboration with academia and industry, has announced a new trial to open in Oxford. The trial will test an experimental drug from AstraZeneca in patients with advanced oesophago-gastric cancer – a disease for which no well-established standard treatments exist. Cancer Research UK’s Drug Development Office (DDO), in collaboration with academia and industry, has announced a new trial to open in Oxford. The trial will test an experimental drug from AstraZeneca in patients with advanced oesophago-gastric cancer – a disease for which no well-established standard treatments exist.

17 August 2012

• Health & Medicine

Cancer Research UK launches trial of experimental drug combination for advanced stomach and oesophageal cancer

Cancer Research UK’s Drug Development Office (DDO) has joined forces with academia and industry to open a clinical trial that will test an experimental drug from AstraZeneca called AZD4547 in combination with standard chemotherapy to treat a group of patients with advanced stomach or oesophageal cancer. Cancer Research UK’s Drug Development Office (DDO) has joined forces with academia and industry to open a clinical trial that will test an experimental drug from AstraZeneca called AZD4547 in combination with standard chemotherapy to treat a group of patients with advanced stomach or oesophageal cancer.

8 June 2012

• Health & Medicine

Cancer Research UK launches groundbreaking research centre in Oxford

A new centre launched today will cement Oxford's place at the forefront of cancer research, and form one of the final links in a unique chain of Cancer Research UK Centres across the country. A new centre launched today will cement Oxford's place at the forefront of cancer research, and form one of the final links in a unique chain of Cancer Research UK Centres across the country.

15 March 2011

Deprived cancer patients face fatal health problems

Cancer patients from deprived backgrounds are more likely to develop life-threatening health problems, research published today (Wednesday) in the British Journal of Cancer* shows. Cancer patients from deprived backgrounds are more likely to develop life-threatening health problems, research published today (Wednesday) in the British Journal of Cancer* shows.

24 November 2010

• Health & Medicine

Stomach cancer deaths lowest for forty years

Deaths from stomach cancer are the lowest since UK records began nearly 40 years ago, according to new Cancer Research UK figures released today (Thursday). Deaths from stomach cancer are the lowest since UK records began nearly 40 years ago, according to new Cancer Research UK figures released today (Thursday).

24 June 2010

• Health & Medicine

Scientists take the first step to targeted treatment for stomach cancer

Researchers have identified a protein that plays an important role in the development of stomach cancers and that could one day be a target for new treatments for the disease, according to research published today* (Wednesday) in the British Journal of Cancer. Researchers have identified a protein that plays an important role in the development of stomach cancers and that could one day be a target for new treatments for the disease, according to research published today* (Wednesday) in the British Journal of Cancer.

12 August 2009

• Health & Medicine

Stomach cancer cases almost halve over the last 30 years

NEW Cancer Research UK figures out today reveal that stomach cancer cases in Great Britain have dropped by nearly half from around 14,000 in 1975 to 7,485 in 2006. NEW Cancer Research UK figures out today reveal that stomach cancer cases in Great Britain have dropped by nearly half from around 14,000 in 1975 to 7,485 in 2006.

6 August 2009

Aspirin cuts stomach cancer risk

Aspirin users could be 36 per cent less likely to get a type of stomach cancer, according to a study published in the British Journal of Cancer*. Aspirin users could be 36 per cent less likely to get a type of stomach cancer, according to a study published in the British Journal of Cancer*.

6 February 2009